Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Functional dyspepsia
- Dyspeptic symptoms
- Dyspepsia subgroups
- Rome IV: functional dyspepsia (FD)
- Rome IV: postprandial distress syndrome (PDS)
- Rome IV: epigastric pain syndrome (EPS)
- Dyspepsia/GERD/IBS
- Motor and sensory pathophysiology
- Delayed gastric emptying (GE)
- Acid hypersensitivity in functional dyspepsia
- Symptoms of functional dyspepsia
- The pathophysiology of functional dyspepsia
- Treatment paradox
- Functional dyspepsia: unclear natural history
- Diagnosis of functional dyspepsia
- Treatment options for functional dyspepsia
- Treatment strategy
- Functional dyspepsia and diet
- Does H. pylori treatment relieve NUD symptoms?
- What about H. pylori?
- H2RAs for functional dyspepsia
- Proton pump inhibitors in functional dyspepsia
- Randomized controlled trials of PPIs in NUD
- Prokinetic systematic review
- Prokinetic therapy forest plot
- Prokinetic results
- Evidence for prokinetic therapies
- Evidence for prokinetic therapies (2)
- Serotoninergic agents
- Functional dyspepsia: SSRIs/SNRIs
- Pain modulation
- Treatment comparisons
- Non-pharmacological treatment
- Psychotherapy in functional dyspepsia
- Herbal remedies for functional dyspepsia
- Alternative medicine: peppermint oil
- Alternative medicine: Iberogast (STW5)
- Thank you for listening
Topics Covered
- Symptoms of functional dyspepsia
- Dyspepsia subgroups
- PDS and EPS
- Diagnosis of functional dyspepsia
- Treatment strategy and options for functional dyspepsia
- H. pylori eradication
- Proton pump inhibitors
- Evidence for prokinetic therapies
- Serotonergic agents
- Selective serotonin reuptake inhibitors
- Non-pharmacological treatments
- Psychotherapy
- Herbal remedies
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kuo, B. (2020, April 29). Disorders of gastric function: gastroparesis and functional dyspepsia 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/CLAY1210.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
Disorders of gastric function: gastroparesis and functional dyspepsia 2
Published on April 29, 2020
17 min
A selection of talks on Gastroenterology & Nephrology
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome back to part two of this presentation.
In this portion, I will be speaking about functional dyspepsia.
0:09
I'd like to move over to functional dyspepsia,
which I mentioned before is part of the upper GI neuromuscular dysfunction spectrum.
0:18
Dyspepsia patients will complain of upper abdominal symptoms,
these include persistent pain or discomfort arising in the upper abdomen,
early satiety, bloating, nausea, vomiting, and belching,
or they may complain of their symptoms worsening postprandially,
and there's a natural fluctuation of these symptoms over time.
0:37
There are subgroups such as ulcer-like dyspepsia, dysmotility-like dyspepsia,
nonspecific, where patients don't fulfill criteria for
various groups or even heartburn or reflux-like dyspepsia.
0:50
This has all been more formally codified by
an evolving criteria called the Rome criteria and we're up to its fourth iteration.
So functional dyspepsia is now characterized by the Rome criteria,
it's one or more of the following symptoms which have to be bothersome,
postprandial fullness, early satiation,
epigastric pain or epigastric burning.
There needs to be no evidence of structural disease,
which is usually done by upper endoscopy,
that is likely to explain the patient's symptoms,
and they have to have their symptoms for at least three months with
the symptom onset at least being six months before diagnosis.
1:24
The functional dyspepsia group can be further
characterized formerly with postprandial distress syndrome,
including bothersome postprandial fullness occurring after ordinary-sized meals,
at least several times a week or early
satiation that prevents finishing of regular meals,
at least several times a week.
There can be upper abdominal bloating or postprandial nausea or excessive belching,
which can be supported but not necessarily for the criteria,
and this may coexist with the other subcategory of functional dyspepsia called EPS.
Hide